dry eye disease

Showing 51 - 75 of 149

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dry Eye Disease, Sjögren Syndrome Trial in United States (Tivanisiran sodium ophthalmic solution, Vehicle ophthalmic solution)

Recruiting
  • Dry Eye Disease
  • Sjögren Syndrome
  • Tivanisiran sodium ophthalmic solution
  • Vehicle ophthalmic solution
  • Birmingham, Alabama
  • +38 more
Sep 15, 2022

Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)

Completed
  • Dry Eye Disease
  • CequaTM (Cyclosporine 0.09%) ophthalmic solution
  • Fort Myers, Florida
  • +4 more
Sep 8, 2022

Multimodal Screening of Dry Eye Disease

Recruiting
  • Dry Eye Disease
  • No Dye BreakUp Time
  • Le Kremlin-Bicêtre, Val De Marne, France
    Opthtalmology Departement, Bicêtre Hospital
Sep 5, 2022

Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in United States (Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine

Completed
  • Dry Eye Disease
  • Kerato Conjunctivitis Sicca
  • Pilocarpine Ophthalmic Topical Cream, Dose 1
  • +3 more
  • Chandler, Arizona
  • +18 more
Aug 26, 2022

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)

Completed
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • OTX-101 0.05%
  • +2 more
  • Cleveland, Ohio
    (unnamed)
Aug 26, 2022

Dry Eye Disease Trial in Venice (Varenicline solution, Placebo nasal spray (OC-01 Vehicle Nasal Spray))

Recruiting
  • Dry Eye Disease
  • Varenicline solution
  • Placebo nasal spray (OC-01 Vehicle Nasal Spray)
  • Venice, Florida
    Stephenson Eye Associates
Aug 23, 2022

Dry Eye Disease Trial in China (Varenicline Tartrate Nasal Spray, Placebo (vehicle))

Recruiting
  • Dry Eye Disease
  • Varenicline Tartrate Nasal Spray
  • Placebo (vehicle)
  • Hefei, Anhui, China
  • +19 more
Aug 16, 2022

Dry Eye Disease Trial in Newport Beach (0.003% AR-15512 to be administered in both eyes, Vehicle to be administered in both

Completed
  • Dry Eye Disease
  • 0.003% AR-15512 to be administered in both eyes
  • Vehicle to be administered in both eyes
  • Newport Beach, California
    Eye Research Foundation
Aug 9, 2022

Dry Eye Disease Trial (SHJ002/Vehicle)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Aug 8, 2022

Dry Eye Disease Trial (AR-15512 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Aug 5, 2022

Dry Eye Disease, Meibomian Gland Dysfunction Trial in New York, Harrisburg (IPL_RF_MGX)

Recruiting
  • Dry Eye Disease
  • Meibomian Gland Dysfunction
  • IPL_RF_MGX
  • New York, New York
  • +1 more
Aug 1, 2022

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Dry Eye Disease, Cataract Trial in Valladolid (Systane Hydration lubricant eye drops)

Recruiting
  • Dry Eye Disease
  • Cataract
  • Systane Hydration lubricant eye drops
  • Valladolid, Spain
    Principal Investigator
Jul 11, 2022

Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye

Recruiting
  • Dry Eye Disease
  • Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
  • Oslo, Norway
    The Norwegian Dry Eye Clinic
Jun 27, 2022

Dry Eye Disease Trial in United States (Tivanisiran sodium ophthalmic solution, Vehicle ophthalmic solution)

Recruiting
  • Dry Eye Disease
  • Tivanisiran sodium ophthalmic solution
  • Vehicle ophthalmic solution
  • Chandler, Arizona
  • +24 more
Jun 24, 2022

Dry Eye Disease Trial in Mexico City (OC-01 0.1% 0.6 mg/ml, OC-01 (varenicline) nasal spray: 0.2 % (1.2 mg/ml), comparator)

Completed
  • Dry Eye Disease
  • OC-01 0.1% 0.6 mg/ml
  • +2 more
  • Mexico City, Mexico
    Mexico City
Mar 8, 2022

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface

Recruiting
  • Dry Eye Disease
  • oGVHD
  • The standard care exam and biological specimens' collection
  • Baltimore, Maryland
    Geenebaum Cancer Center, University of Maryland Medical Center
Jun 2, 2022

Dry Eye Disease Trial in United States (NOV03, Saline Solution)

Completed
  • Dry Eye Disease
  • Phoenix, Arizona
  • +27 more
May 4, 2022

Dry Eye Disease Trial in Patras (Oxatrex)

Completed
  • Dry Eye Disease
  • Patras, Achaea, Greece
    Department of Ophthalmology, General University Hospital of Patr
Apr 14, 2022

Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium

Completed
  • Dry Eye Disease
  • SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
  • +6 more
  • Phoenix, Arizona
  • +39 more
Apr 10, 2022

Dry Eye Disease Trial in United States (Systane Complete)

Completed
  • Dry Eye Disease
  • Systane Complete
  • Kansas City, Missouri
  • +3 more
Mar 28, 2022

Dry Eye Disease Trial in Andover, Raynham, Memphis (ST-100 Ophthalmic Solution, Placebo Ophthalmic Solution)

Completed
  • Dry Eye Disease
  • ST-100 Ophthalmic Solution
  • Placebo Ophthalmic Solution
  • Andover, Massachusetts
  • +2 more
Feb 22, 2022

Dry Eye Disease Trial in Seoul (Real Pulse Electrical Stimulation (NuEyne 01), Sham Pulse Electrical Stimulation)

Completed
  • Dry Eye Disease
  • Real Pulse Electrical Stimulation (NuEyne 01)
  • Sham Pulse Electrical Stimulation
  • Seoul, Korea, Republic of
    Department of Ophthalmology, Samsung Medical Center
Mar 7, 2022

Dry Eye Disease Trial in Louisville, Nashville (OC-02 (simpinicline) nasal spray, Placebo (vehicle) nasal spray)

Completed
  • Dry Eye Disease
  • OC-02 (simpinicline) nasal spray
  • Placebo (vehicle) nasal spray
  • Louisville, Kentucky
  • +1 more
Feb 25, 2022